A study reported a notable increase in the expression level of SHMT2 in BLCA patients, indicating its possible involvement in regulating cell proliferation, cell cycle, and apoptosis in BLCA [62]. The gene discussed is SHMT2; the disease is bladder transitional cell carcinoma.